Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
753
-
Total 13F shares, excl. options
-
272,953,409
-
Shares change
-
+29,521,224
-
Total reported value, excl. options
-
$9,684,497,290
-
Value change
-
+$1,015,848,573
-
Put/Call ratio
-
1.01%
-
Number of buys
-
220
-
Number of sells
-
-452
-
Price
-
$35.47
Significant Holders of GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) as of Q4 2017
885 filings reported holding GSK - GLAXOSMITHKLINE PLC - SPONSORED ADR as of Q4 2017.
GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) has 753 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 272,953,409 shares
.
Largest 10 shareholders include DODGE & COX (44,083,293 shares), ROYAL BANK OF CANADA (25,539,319 shares), FMR LLC (19,680,711 shares), PRICE T ROWE ASSOCIATES INC /MD/ (16,570,353 shares), Fisher Asset Management, LLC (12,779,721 shares), STATE STREET CORP (10,261,757 shares), RENAISSANCE TECHNOLOGIES LLC (9,668,300 shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (8,410,527 shares), WELLS FARGO & COMPANY/MN (7,156,220 shares), and BANK OF AMERICA CORP /DE/ (6,754,065 shares).
This table shows the top 753 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.